1,25(OH)2-vitamin D3 actions on cell proliferation, size, gene expression, and receptor localization, in the HL-1 cardiac myocyte

被引:145
作者
Nibbelink, Karl A. [1 ]
Tishkoff, Daniel X. [1 ]
Hershey, Stephen D. [1 ]
Rahman, Ayesha [1 ]
Simpson, Robert U. [1 ]
机构
[1] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA
关键词
1,25-dihydroxyvitamin D-3; heart; HL-1; cell;
D O I
10.1016/j.jsbmb.2006.12.099
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The steroid hormone 1.25(OH)(2)-vitamin D-3 [1,25D] has been shown to affect the growth and proliferation of primary cultures of ventricular myocytes isolated from neonatal rat hearts. The research presented here shows that the vitamin D receptor [VDR] is present in murine cardiac myocytes (HL-1 cells). and that 1,25D affects the growth, proliferation and morphology of these cells. In addition we show that 1,25D effects expression of ANP, myotrophin, and c-myc. Furthermore, 1,25D effects expression and localization of the VDR within the cell. Murine HL-1 cardiac myocytes were grown and treated with 1,25D in culture, and growth and morphology were assessed with microscopic analysis. Cells were counted and protein levels were evaluated through Western blot analysis. Subcellular localization of the VDR was determined using immunofluorescence and confocal microscopy. 1,25D was found to decrease proliferation and alter cellular morphology of the HL-1 cells. Treatment with 1,25D increased expression of myotrophin while decreasing expression of atrial natriuretic peptide [ANP] and c-myc. 1,25D treatment also increased expression and nuclear localization of the VDR in these cardiac myocytes. Thus 1,25D is an important hormone involved in modulating and maintaining heart cell structure and function. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:533 / 537
页数:5
相关论文
共 13 条
[1]   Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications [J].
Clerico, A ;
Recchia, FA ;
Passino, C ;
Emdin, M .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2006, 290 (01) :H17-H29
[2]   The vitamin D epidemic and its health consequences [J].
Holick, MF .
JOURNAL OF NUTRITION, 2005, 135 (11) :2739S-2748S
[3]   The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1α,25(OH)2-vitamin D3 in vivo and in vitro [J].
Huhtakangas, JA ;
Olivera, CJ ;
Bishop, JE ;
Zanello, LP ;
Norman, AW .
MOLECULAR ENDOCRINOLOGY, 2004, 18 (11) :2660-2671
[4]   Vitamin D and its analogues: Do they protect against cardiovascular disease in patients with kidney disease? [J].
Levin, A ;
Li, YC .
KIDNEY INTERNATIONAL, 2005, 68 (05) :1973-1981
[5]   The rise and fall of myotrophin in heart failure [J].
McMurray, JJV ;
Hillier, C .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (04) :726-727
[6]  
OCONNELL T, 1995, 1 2K DIYDROXYVITAMIN, P191
[7]  
OConnell TD, 1997, AM J PHYSIOL-HEART C, V272, pH1751
[8]   INHIBITION OF CARDIAC MYOCYTE MATURATION BY 1,25-DIHYDROXYVITAMIN D-3 [J].
OCONNELL, TD ;
GIACHERIO, DA ;
JARVIS, AK ;
SIMPSON, RU .
ENDOCRINOLOGY, 1995, 136 (02) :482-488
[9]   Immunochemical identification of the 1,25-dihydroxyvitamin D-3 receptor protein in human heart [J].
OConnell, TD ;
Simpson, RU .
CELL BIOLOGY INTERNATIONAL, 1996, 20 (09) :621-624
[10]   1,25-DIHYDROXYVITAMIN D-3 REGULATION OF MYOCARDIAL GROWTH AND C-MYC LEVELS IN THE RAT-HEART [J].
OCONNELL, TD ;
SIMPSON, RU .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 213 (01) :59-65